Medical Condition

delirium

Total Trials

11

Recruiting Now

11

Trial Phases

Phase 2, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for delirium sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — delirium Clinical Trials

How many clinical trials are currently recruiting for delirium?

ClinicalMetric currently tracks 11 actively recruiting clinical trials for delirium, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for delirium?

delirium research spans Phase 2 (4 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a delirium clinical trial?

Eligibility criteria for delirium trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Phase 3

Top Sponsors

Penn State University 1 trial

University of Milano Bicocca 1 trial

Ciusss de L'Est de l'Île de Montréal 1 trial

M.D. Anderson Cancer Center 1 trial

Peking Union Medical College Hospital 1 trial

Recruiting Clinical Trials

NCT05915377

Recruiting

Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation

Penn State University

View Trial →

NCT07804498 Phase 2

Recruiting

CITADEL: Effectiveness of CITicoline in Preventing Cognitive Decline After DELirium

University of Milano Bicocca

View Trial →

NCT05713877 Phase 2

Recruiting

Melatonin for Treatment of Delirium in Critically Ill Adult Patients

Ciusss de L'Est de l'Île de Mo...

View Trial →

NCT05431595 Phase 2, Phase 3

Recruiting

Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy

M.D. Anderson Cancer Center

View Trial →

NCT05525702

Recruiting

VR Interventions to Reduce the Prevalence of Delirium in ICU Patients

Peking Union Medical College H...

View Trial →

NCT07218484

Recruiting

VoiceLove Digital Therapy for Delirium in the ICU

The Methodist Hospital Researc...

View Trial →

NCT06509191 Phase 2, Phase 3

Recruiting

The Use of Melatonin for Delirium Prevention in Medically Hospitalized Patients

Sultan Qaboos University

View Trial →

NCT06718764

Recruiting

Neurosteer Bedside Monitoring System

Icahn School of Medicine at Mo...

View Trial →

NCT05127265

Recruiting

Pervasive Sensing and AI in Intelligent ICU

University of Florida

View Trial →

NCT05195034

Recruiting

Effect of Dexmedetomidine on Postoperative Delirium After Awake Craniotomies

Beijing Tiantan Hospital

View Trial →

NCT07369258

Recruiting

Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit

HOSPITAL BRITANICO DE BUENOS A...

View Trial →

Related Conditions

critical illness (2) delirium in old age (1) delirium with dementia (1) delirium superimposed on dementia (1) cognitive decline (1) epileptics (1) neuroleptics (1) sedation (1) agitation (1) pain (1) confusion (1) dexmedetomidine (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology